Company intelligence / Profile preview

Regrow Biosciences

Mumbai (Andheri Kurla Road HQ), Maharashtra, Indiaregrow.in ↗

Ownership: Private
Employees: ~115
Development stage: Commercial

Overview

Regrow Biosciences has developed and commercialized patient-specific regenerative therapies, including bone cell therapy for AVN. The company claims successful clinical trials with over 1500 patients treated and regulatory recognition from the US FDA and EMA for its Ossgrow® product.

Therapeutic areas: RheumatologyMen's Health
Modalities: Cell therapyStem cell therapy
Industry: Biotech

Drug pipeline

6 assets

CARTIGROW

Unknown

5 more assets in the full pipeline.

Request access →

Partnerships

340 doctor-partner network across 46 Indian cities [1]. No major pharma partnerships listed.

Beyond the preview

Go deeper on Regrow Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regrow Biosciences.

Explore the full profile